Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer PICKER DONALD H
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Foster Jonathan P.
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer PICKER DONALD H
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Foster Jonathan P.
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Foster Jonathan P.
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V
Moleculin Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Foster Jonathan P.
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Director George Robert E.
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Foster Jonathan P.
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer PICKER DONALD H
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer PICKER DONALD H
Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Foster Jonathan P.
No Data